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Table 1 Baseline ECG measurements, baseline mean arterial pressure and cardiac response to intravenous adenosine 112 µg kg–1 before and during 1% isoflurane
anaesthesia. Values are mean (SD). *Two patients did not develop adenosine-induced PR prolongation while awake, and these two patients, together with a third,
did not develop it during anaesthesia. Paired t tests were therefore performed only on data from the 13 patients with PR prolongation both before and during anaesthesia
Before anaesthesia During anaesthesia P value
Baseline PR interval (ms) 177 (25) 166 (24) 0.007
Baseline PP interval (ms) 1067 (168) 1099 (253) 0.546
Baseline mean arterial pressure (mm Hg) 88 (11) 76 (9) 0.003
Time to onset of PR prolongation in 13 patients (s)* 9.9 (3) 12.8 (5) 0.032
Duration of PR prolongation in 13 patients (s)* 10.1 (3) 10.1 (4) 0.595
Total number of non-conducted P waves 27 12 0.016
Minimum PP interval after adenosine (% of baseline) 75 (8) 87 (6) 0.001
Adenosine: electrophysiologic effects and therapeutic use forthe direct cardiac effects of an intravenous bolus of adenos-
terminating paroxysmal supraventricular tachycardia. Circulationine. This could reflect anaesthesia-induced sympatholysis.
1983; 68: 1254–63The attenuation of the atrioventricular blocking effect of
2 Hillel Z, Thys DM. Electrocardiography. In: Miller RD, ed.adenosine shown in this study is a consideration when an
Anesthesia. New York: Churchill Livingstone, 1994; 1241
anaesthetized patient develops supraventricular tachycardia.
3 Ellenbogen KA, Thames MD, DiMarco JP, Sheehan H, Lerman BB.A standard intravenous adenosine 3, 6, 12 mg regimen Electrophysiological effects of adenosine in the transplanted human
without additional higher doses is currently recommended. heart: evidence of supersensitivity. Circulation 1990; 81: 821–8
We suggest that, for the anaesthetized patient, the current 4 Moser GH, Schrader J, Deussen A. Turnover of adenosine in
maximum dose presented above needs to be reviewed. plasma of human and dog blood. Am J Physiol 1989; 256: C799–806
5 Biaggioni I, Killian T, Mosquedo-Garcia R, Robertson RM,
References Robertson D. Adenosine increases sympathetic nerve traffic in
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Oxygen saturation and carbon dioxide values should be monitored during high-frequency jet
ventilation (HFJV). Modern transcutaneous PCO2 (PtcCO2) measurement allows the estimation
of ventilation efficiency. We studied how tests of lung function could predict carbon dioxide
elimination during HFJV. Lung function tests from 180 adult patients undergoing rigid
bronchoscopy were analysed as factors affecting carbon dioxide elimination. The lung function
test results showed a significant relationship with the efficiency of carbon dioxide elimination;
the greatest impairment of carbon dioxide elimination was found in patients with combined
abnormalities of lung function. Further factors associated with difficult carbon dioxide elimination
were male gender and elevated body weight. Of the patients investigated, 72% had normal
carbon dioxide elimination, whereas in 23% hypercapnia could be avoided only by increasing
the driving pressure. The prevalence of abnormal preoperative lung function test results
predicts (sensitivity 76%, positive predictive value 27%) impaired carbon dioxide elimination
during jet ventilation and rigid bronchoscopy.
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High-frequency jet ventilation (HFJV) is a convenient Systems, Hirzel, Switzerland) via the rigid bronchoscope. A
method of ventilation during rigid bronchoscopy, since it respiratory frequency of 150 cycles min–1 and an inspiration
offers optimal visibility and easy access for diagnostic and duration of 40% were set during the study. Therefore, the
surgical instruments into the airway. However, monitoring DP was the only variable in the HFJV setting.
of gas exchange is more difficult than during conventional The DP was set at 1.5, 2.0 and 2.5 atm for 5 min each,
ventilation and requires special equipment. We have recently and the resulting PtcCO2 was documented 3 min after each
described a new transcutaneous blood gas sensor prototype, change of DP setting. If oxygenation was poor (SpO2
the SpO2-PtcCO2 ear probe (Linde Medical Instruments, 89%), HFJV was supplemented by manually assisted
Basel, Switzerland). This device provides reliable carbon ventilation. ECCO2 values calculated at various DP settingsdioxide partial pressure values compared with simultan- were averaged. The physical and clinical characteristics
eously determined PaCO2, and has an in vivo latency period of patients with normal carbon dioxide elimination were
of 5720 s.1 Because of the speed and ease of use of this compared with those of patients with impaired elimination
device, we now routinely use transcutaneous carbon dioxide by the use of the Mann–Whitney test. The influence of lung
measurement during HFJV as an approximation for PaCO2. function on ECCO2 was tested for dissimilarity by one-waySince the jet driving pressure (DP) and the resulting analysis of variance (ANOVA). Post hoc comparisons of
transcutaneous PCO2 (PtcCO2) values are inversely related, categories were performed using the Bonferroni–Dunn test.
we calculate a carbon dioxide elimination coefficient Frequencies were examined for variability by the chi-(ECCO2) which helps to quantify the individual carbon squared test; P  0.05 was considered significant. In eight
dioxide elimination capacity under HFJV and under stand- patients the SpO2 could not be maintained continuouslyardized conditions.2
above 89%, which prevented further analysis of carbonA value of 1.0 results if PtcCO2 is normal (37.5 mm Hg) dioxide elimination under standardized study conditions.during jet ventilation with a moderate DP of 2.0 atm and Thus, the data come from 172 patients. PtcCO2 values hadrepresents a normal carbon dioxide elimination capacity.
a range of 24.8–66.8 mm Hg. One hundred and thirty-fiveReduced values indicate impaired carbon dioxide elimina- patients had normal carbon dioxide elimination (ECCO2 tion. As an empirical cut-off value, we use an ECCO2 of 0.75), and in 37 patients carbon dioxide elimination was0.75 to differentiate between normal and compromised
compromised (ECCO2  0.75). Patients with compromisedcarbon dioxide elimination. We set out to assess the relation
carbon dioxide elimination had a significantly greater bodybetween preoperative lung function test results and carbon
weight and a smaller VC and FEV1, and the percentage ofdioxide elimination during jet ventilation for rigid bron-
males was higher in this group of patients (Table 1).choscopy.
Allocation of patients to the four prospectively defined
patients the SpO2 could not be maintained continuously with
normal lung function, (ii) 57 patients (33%) with obstructiveMethods and results
abnormality, (iii) 22 patients (13%) with restrictive abnor-After informed consent had been obtained, 180 adult patients
mality and (iv) 24 patients (14%) with combined (obstructiveof ASA physical status 1–4 who were scheduled for elective
plus restrictive) abnormality. Elimination of carbon dioxide,interventional rigid bronchoscopy under general anaesthesia
as assessed by ECCO2, was best in patients with normaland HFJV were included in this study. Vital capacity (VC)
lung function (P  0.0007 in the overall ANOVA) andand forced expiratory volume in 1 s (FEV1) were measured
deteriorated progressively in patients with obstructive,and compared with values predicted from standard equa-
restrictive and combined abnormality.tions.3 A restrictive pattern was assumed if the measured VC
Normal values of lung function variables (VC and/orwas below 70% of the predicted value, and an obstructive
FEV1) had a negative predictive value of 87% for normalabnormality if the measured FEV1 was below 70% of the
carbon dioxide elimination (ECCO2  0.75), whereas thepredicted value.
prevalence of at least one pathological lung function variableTotal intravenous anaesthesia (TIVA) was conducted with
resulted in a positive predictive value of only 27% forpropofol and remifentanil for induction and maintenance
compromised carbon dioxide elimination (ECCO2and succinylcholine for muscle relaxation. In addition to
 0.75). Of patients with impaired carbon dioxide elimina-usual monitoring, continuous transcutaneous blood gas
tion (ECCO2  0.75), 76% had abnormal lung function testsmeasurement with a calibrated SpO2-PtcCO2 ear-clip sensor (sensitivity) and normal results were present in only 44%prototype (Linde Medical Instruments, Basel,
of patients with normal carbon dioxide elimination (ECCO2Switzerland) was used.1 Jet ventilation was performed with
an AMS 1000 Universal Jet Ventilator- (Acutronic Medical  0.75) (specificity).
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Table 1 Biometrical and clinical data during jet ventilation for rigid elimination.2 5 6 The same is true for abnormal lung function,
bronchoscopy in patients with normal and compromised carbon dioxide but this depends on the type and degree of the abnormality.elimination. Frequencies were compared with the chi-squared test, the other
variables with the Mann–Whitney test). Values are mean (SD). n.s.  not Surprisingly, obstructive lung disease, which is usually
significant. considered an important hindrance to carbon dioxide elim-
ination during jet ventilation,7 8 was less relevant thanNormal Compromised Statistical
CO2 elimination CO2 elimination significance restrictive lung function. However, the preoperative
(ECCO2 > 0.75) (ECCO2 < 0.75) abnormal lung function predicts difficult carbon dioxide
elimination (sensitivity 76%) but normal results are notPatients (n) 135 37
Males (n) 82 (63%) 29 (76%) P0.05 good predictors of normal carbon dioxide elimination during
Age (years) 58 (17–31) 59 (83–78) n.s. jet ventilation (specificity 44%).
Height (cm) 171 (9) 171 (7) n.s. In summary, most patients with abnormal pulmonary func-Weight (kg) 72 (13) 79 (15) P0.05
Predicted VC (l) 3.81 (0.87) 3.79 (0.65) n.s. tion tests undergoing rigid bronchoscopy (96%) can be ventil-
Actual VC (l) 3.16 (0.96) 2.57 (0.93) P0.05 ated adequately with HFJV. Measurement of lung function
Predicted FEV1 (l) 3.26 (0.77) 3.27 (0.55) n.s. variables such as VC and FEV1 and the prevalence of otherActual FEV1 (l) 2.22 (0.78) 1.73 (0.73) P0.05
FEV1100/VC (%) 70.4 (12.9) 67.8 (15.3) n.s. cofactors, such as male gender and elevated body weight, can
Ventilation 14 (11) 14 (7) n.s. help to estimate the expected carbon dioxide elimination.
duration (min) Patients with normal carbon dioxide elimination will requireMean PtcCO2 40.8 (6.9) 52.4 (6.1) P0.01(mm Hg) a lower DP. This has the benefits of lowering airway pressure
Mean DP (atm) 1.9 (0.3) 2.3 (0.3) P0.01 to the necessary minimum and reducing the adverse effects
Mean ECCO2 1.02 (0.18) 0.66 (0.08) P0.01 of HFJV, such as cooling and drying of the tracheobronchial
Lung function categories (n) epithelium.Normal 60 9
Obstructive 48 8 P0.007Restrictive 13 10 } Acknowledgements
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